These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 2525101)

  • 21. [Functional and morphological characterization of alveolar macrophages from patients with pulmonary sarcoidosis].
    Barth J; Petermann W; Kreipe H; Radzun HJ; Parwaresch MR
    Immun Infekt; 1990 Feb; 18(1):20-2. PubMed ID: 2312148
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Controlled study of linear growth in asthmatic children during treatment with inhaled glucocorticosteroids.
    Wolthers OD; Pedersen S
    Pediatrics; 1992 May; 89(5 Pt 1):839-42. PubMed ID: 1579391
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Sarcoidosis: immunopathology and criteria of biological activity].
    Müller-Quernheim J; Ménard O
    Rev Mal Respir; 1995; 12(6):525-31. PubMed ID: 8677346
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suppressive mechanisms of alveolar macrophages in interstitial lung diseases: role of soluble factors and cell-to-cell contact.
    Fireman E; Ben-Efraim S; Spinrad S; Topilsky M; Greif J
    Eur Respir J; 1993 Jul; 6(7):956-64. PubMed ID: 8370444
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Granulocyte function in the airways of allergen-challenged pigs: effects of inhaled and systemic budesonide.
    Fornhem C; Peterson CG; Dahlbäck M; Scheynius A; Alving K
    Clin Exp Allergy; 1996 Dec; 26(12):1436-48. PubMed ID: 9027445
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of budesonide in the treatment of pulmonary sarcoidosis.
    Selroos OB
    Ann N Y Acad Sci; 1986; 465():713-21. PubMed ID: 3014964
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The response of alveolar lymphocytes induced by Propionibacterium acnes in pulmonary sarcoidosis: correlation with clinical studies, pulmonary function studies and bronchoalveolar lavage].
    Nakata Y; Kataoka M; Ejiri T; Mori Y; Hioka T; Maeda T; Hosoya S; Ohnoshi T; Kimura I
    Nihon Kyobu Shikkan Gakkai Zasshi; 1989 Jul; 27(7):837-41. PubMed ID: 2810973
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pathogenetic aspects of sarcoidosis. Importance of local complement synthesis in alveolar macrophages].
    Pettersen HB; Johnson E
    Tidsskr Nor Laegeforen; 1992 May; 112(12):1570-3. PubMed ID: 1615506
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comparison of the effectiveness of budesonide and prednisone in the maintenance treatment of pulmonary sarcoidosis].
    Zych D; Pawlicka L; Zieliński J
    Pol Arch Med Wewn; 1992 Jul; 88(1):30-7. PubMed ID: 1454657
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Chemiluminescent measurements of alveolar macrophages in sarcoidosis patients].
    Winsel K; Christ R; Eckert H; Renner H; Unger U; Grollmuss H
    Z Erkr Atmungsorgane; 1987; 169(1):23-32. PubMed ID: 3673126
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhanced alveolar macrophage-mediated antigen-induced T-lymphocyte proliferation in sarcoidosis.
    Venet A; Hance AJ; Saltini C; Robinson BW; Crystal RG
    J Clin Invest; 1985 Jan; 75(1):293-301. PubMed ID: 3871200
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spontaneous release of granulocyte colony-stimulating factor (G-CSF) by alveolar macrophages in the course of bacterial pneumonia and sarcoidosis: endotoxin-dependent and endotoxin-independent G-CSF release by cells recovered by bronchoalveolar lavage.
    Tazi A; Nioche S; Chastre J; Smiéjan JM; Hance AJ
    Am J Respir Cell Mol Biol; 1991 Feb; 4(2):140-7. PubMed ID: 1703767
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of an inhaled corticosteroid on oxygen radical production by bronchoalveolar cells after allergen or ozone in dogs.
    Stevens WH; Adelroth E; Woolley MJ; Wattie J; Dahlbäck M; O'Byrne PM
    Eur J Pharmacol; 1995 Oct; 293(3):251-7. PubMed ID: 8666043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Inhaled budesonide for chronic obstructive pulmonary disease].
    Weiner P; Zamir D; Beckerman M
    Harefuah; 1997 Jun; 132(11):756-9, 823. PubMed ID: 9223815
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of an inhaled corticosteroid, budesonide, on alveolar macrophage function in smokers.
    Bergstrand H; Björnson A; Blaschke E; Brattsand R; Eklund A; Larsson K; Linden M
    Thorax; 1990 May; 45(5):362-8. PubMed ID: 2166359
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma.
    Haahtela T; Järvinen M; Kava T; Kiviranta K; Koskinen S; Lehtonen K; Nikander K; Persson T; Selroos O; Sovijärvi A
    N Engl J Med; 1994 Sep; 331(11):700-5. PubMed ID: 8058076
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhaled steroids for sarcoidosis?
    Kirsten D
    Eur Respir J; 1995 May; 8(5):679-81. PubMed ID: 7656935
    [No Abstract]   [Full Text] [Related]  

  • 38. The long-term efficacy and safety of two different corticosteroids in chronic sarcoidosis.
    Rizzato G; Riboldi A; Imbimbo B; Torresin A; Milani S
    Respir Med; 1997 Sep; 91(8):449-60. PubMed ID: 9338047
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term therapy with deflazacort in chronic sarcoidosis.
    Rizzato G; Fraioli P; Montemurro L
    Chest; 1991 Feb; 99(2):301-9. PubMed ID: 1846572
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Macrophage-T suppressor cell interference in the lungs of steroid-treated sarcoidosis patients.
    van Maarseveen TC; Mullink H; Stam J; de Groot J
    Am Rev Respir Dis; 1991 Apr; 143(4 Pt 1):839-43. PubMed ID: 1826195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.